HRP930926B1 - Erythromycin derivative - Google Patents
Erythromycin derivativeInfo
- Publication number
- HRP930926B1 HRP930926B1 HR930926A HRP930926A HRP930926B1 HR P930926 B1 HRP930926 B1 HR P930926B1 HR 930926 A HR930926 A HR 930926A HR P930926 A HRP930926 A HR P930926A HR P930926 B1 HRP930926 B1 HR P930926B1
- Authority
- HR
- Croatia
- Prior art keywords
- represents hydrogen
- lower alkyl
- represent
- pair
- different
- Prior art date
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000003341 7 membered heterocyclic group Chemical group 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 210000004051 gastric juice Anatomy 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13382892 | 1992-05-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP930926A2 HRP930926A2 (en) | 1995-02-28 |
| HRP930926B1 true HRP930926B1 (en) | 2000-10-31 |
Family
ID=15113997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR930926A HRP930926B1 (en) | 1992-05-26 | 1993-05-24 | Erythromycin derivative |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5658888A (ko) |
| EP (1) | EP0643068B1 (ko) |
| JP (1) | JP3068367B2 (ko) |
| KR (1) | KR100226311B1 (ko) |
| CN (1) | CN1036199C (ko) |
| AT (1) | ATE169927T1 (ko) |
| AU (1) | AU659740B2 (ko) |
| CA (1) | CA2117883C (ko) |
| DE (1) | DE69320476T2 (ko) |
| DK (1) | DK0643068T3 (ko) |
| ES (1) | ES2120499T3 (ko) |
| HK (1) | HK1009969A1 (ko) |
| HR (1) | HRP930926B1 (ko) |
| IL (1) | IL105810A (ko) |
| MY (1) | MY113693A (ko) |
| SG (1) | SG52785A1 (ko) |
| SI (1) | SI9300281B (ko) |
| TW (1) | TW240230B (ko) |
| WO (1) | WO1993024509A1 (ko) |
| YU (1) | YU48771B (ko) |
| ZA (1) | ZA933679B (ko) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA966601B (en) * | 1995-08-03 | 1997-02-19 | Chugai Pharmaceutical Co Ltd | Process for producing erythromycin derivatives. |
| JP2007204490A (ja) * | 1995-08-03 | 2007-08-16 | Chugai Pharmaceut Co Ltd | エリスロマイシン誘導体の製造方法 |
| US6077943A (en) * | 1996-03-01 | 2000-06-20 | Takeda Chemical Industries, Ltd. | Method of producing erythromycin derivative |
| AU3634397A (en) * | 1996-07-24 | 1998-02-10 | Chugai Seiyaku Kabushiki Kaisha | Erythromycin derivatives |
| WO1998023629A1 (fr) * | 1996-11-26 | 1998-06-04 | Chugai Seiyaku Kabushiki Kaisha | Composes de macrolides comportant une chaine a 13 elements, medicament les contenant et leur procede de preparation |
| US5780605A (en) * | 1997-09-08 | 1998-07-14 | Abbott Laboratories | 6,9-bridged erythromycin derivatives |
| AU2001238476A1 (en) | 2000-02-18 | 2001-08-27 | Kosan Biosciences, Inc. | Motocide compounds |
| KR100554562B1 (ko) * | 2000-09-01 | 2006-03-03 | 쥬가이 세이야쿠 가부시키가이샤 | 에리트로마이신 유도체의 제조 방법 |
| KR100540021B1 (ko) | 2000-10-12 | 2005-12-29 | 쥬가이 세이야쿠 가부시키가이샤 | 신규한 결정 구조를 갖는 에리트로마이신 유도체 및 그의제조 방법 |
| US6906039B2 (en) | 2001-06-13 | 2005-06-14 | Ube Industries, Ltd. | Process for preparation of erythromycin compounds |
| TW200302830A (en) * | 2002-01-11 | 2003-08-16 | Chugai Pharmaceutical Co Ltd | Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate |
| EP2266590A3 (en) | 2002-02-22 | 2011-04-20 | Shire LLC | Active agent delivery sytems and methods for protecting and administering active agents |
| BR0312501A (pt) * | 2002-07-10 | 2005-04-12 | Warner Lambert Co | Combinação de um inibidor alostérico ou metaloproteinase de matriz-13 com um inibidor de ciclooxigenase-2 diferente de celecoxib ou valdecoxib |
| US20040010035A1 (en) * | 2002-07-15 | 2004-01-15 | Ciociola Arthur A. | Gastrointestinal compositions |
| US6986901B2 (en) * | 2002-07-15 | 2006-01-17 | Warner-Lambert Company Llc | Gastrointestinal compositions |
| PT1532131E (pt) * | 2002-08-29 | 2009-02-18 | Pfizer | Compostos motilidos |
| AR043050A1 (es) * | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
| WO2004078770A1 (en) * | 2003-03-05 | 2004-09-16 | Rib-X Pharmaceuticals, Inc. | Bifunctional heterocyclic compounds and methods of making and using the same |
| JP4928261B2 (ja) | 2003-06-18 | 2012-05-09 | トランザイム・ファーマ・インコーポレイテッド | モチリン受容体の大環状拮抗薬 |
| US7407941B2 (en) * | 2003-08-26 | 2008-08-05 | Pfizer, Inc. | N-desmethyl-N-substituted-11-deoxyerythromycin compounds |
| US20050113319A1 (en) * | 2003-08-26 | 2005-05-26 | Christopher Carreras | 11-Deoxy-6,9-ether erythromycin compounds |
| US20070149463A1 (en) * | 2003-10-30 | 2007-06-28 | Oyelere Adegboyega K | Bifunctional macrolide heterocyclic compounds and methods of making and using the same |
| EP1699808A1 (en) * | 2003-11-18 | 2006-09-13 | Rib-X Pharmaceuticals, Inc. | Bifunctional macrolide heterocyclic compounds and methods of making and using the same |
| US7211568B2 (en) * | 2003-12-18 | 2007-05-01 | Kosan Biosciences Incorporated | 9-Desoxoerythromycin compounds as prokinetic agents |
| EP2716647A3 (en) | 2004-02-27 | 2014-08-20 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
| TW200633714A (en) * | 2004-12-28 | 2006-10-01 | Chugai Pharmaceutical Co Ltd | Drugs for the treatment and/or prophylaxis of gastroparesis symptom |
| US7582611B2 (en) | 2005-05-24 | 2009-09-01 | Pfizer Inc. | Motilide compounds |
| EP1934237A2 (en) | 2005-08-24 | 2008-06-25 | Rib-X Pharmaceuticals, Inc. | Triazole compounds and methods of making and using the same |
| EP1928893A2 (en) | 2005-08-24 | 2008-06-11 | Rib-X Pharmaceuticals, Inc. | Triazole compounds and methods of making and using the same |
| EP1960414A4 (en) * | 2005-12-08 | 2008-12-17 | Pfizer | METHOD FOR DEMETHYLATING THE 3-DIMETHYLAMINOGRUPPE OF ERYTHROMYCIN COMPOUNDS |
| EP2431380A3 (en) | 2006-09-11 | 2013-07-03 | Tranzyme Pharma, Inc. | Macrocyclic antagonist of the motilin receptor for treatment of gastrointestinal dysmotility disorders |
| CA2670482C (en) | 2006-12-05 | 2011-10-11 | Pfizer Inc. | Motilide polymorphs |
| US20080287371A1 (en) * | 2007-05-17 | 2008-11-20 | Tranzyme Pharma Inc. | Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60218321A (ja) * | 1984-04-13 | 1985-11-01 | Satoshi Omura | 消化管収縮運動促進剤 |
| JPS6187625A (ja) * | 1984-10-05 | 1986-05-06 | Satoshi Omura | 消化管収縮運動促進剤 |
| DE3689758T2 (de) * | 1985-08-31 | 1994-08-18 | Kitasato Inst | Erythromycinderivat und Verfahren zu dessen Herstellung. |
| JPH0759513B2 (ja) * | 1985-08-31 | 1995-06-28 | 北里研究所（社団法人） | 消化管収縮運動促進剤 |
| US5008249A (en) * | 1985-08-31 | 1991-04-16 | Kitasato Kenkyusho | Therapeutic method of stimulating digestive tract contractile motion in mammals |
| ATE164848T1 (de) * | 1992-01-21 | 1998-04-15 | Abbott Lab | 4''-deoxyerythromycinderivate |
-
1993
- 1993-05-19 MY MYPI93000927A patent/MY113693A/en unknown
- 1993-05-24 HR HR930926A patent/HRP930926B1/xx not_active IP Right Cessation
- 1993-05-25 YU YU36693A patent/YU48771B/sh unknown
- 1993-05-25 IL IL10581093A patent/IL105810A/en not_active IP Right Cessation
- 1993-05-25 SI SI9300281A patent/SI9300281B/sl not_active IP Right Cessation
- 1993-05-25 TW TW082104109A patent/TW240230B/zh active
- 1993-05-26 AT AT93910399T patent/ATE169927T1/de not_active IP Right Cessation
- 1993-05-26 SG SG1996009490A patent/SG52785A1/en unknown
- 1993-05-26 DK DK93910399T patent/DK0643068T3/da active
- 1993-05-26 AU AU40897/93A patent/AU659740B2/en not_active Ceased
- 1993-05-26 CA CA002117883A patent/CA2117883C/en not_active Expired - Fee Related
- 1993-05-26 ES ES93910399T patent/ES2120499T3/es not_active Expired - Lifetime
- 1993-05-26 EP EP93910399A patent/EP0643068B1/en not_active Expired - Lifetime
- 1993-05-26 KR KR1019940704274A patent/KR100226311B1/ko not_active IP Right Cessation
- 1993-05-26 ZA ZA933679A patent/ZA933679B/xx unknown
- 1993-05-26 CN CN93106467A patent/CN1036199C/zh not_active Expired - Fee Related
- 1993-05-26 WO PCT/JP1993/000702 patent/WO1993024509A1/ja active IP Right Grant
- 1993-05-26 DE DE69320476T patent/DE69320476T2/de not_active Expired - Lifetime
- 1993-05-26 US US08/318,814 patent/US5658888A/en not_active Expired - Lifetime
- 1993-05-26 JP JP5124514A patent/JP3068367B2/ja not_active Expired - Fee Related
-
1998
- 1998-09-24 HK HK98110895A patent/HK1009969A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0643068B1 (en) | 1998-08-19 |
| ATE169927T1 (de) | 1998-09-15 |
| SI9300281B (en) | 2001-02-28 |
| JP3068367B2 (ja) | 2000-07-24 |
| DE69320476D1 (en) | 1998-09-24 |
| ZA933679B (en) | 1993-12-21 |
| ES2120499T3 (es) | 1998-11-01 |
| SI9300281A (sl) | 1993-12-31 |
| HK1009969A1 (en) | 1999-09-10 |
| AU4089793A (en) | 1993-12-30 |
| DK0643068T3 (da) | 1999-02-08 |
| JPH0656873A (ja) | 1994-03-01 |
| IL105810A (en) | 1998-12-27 |
| HRP930926A2 (en) | 1995-02-28 |
| AU659740B2 (en) | 1995-05-25 |
| MY113693A (en) | 2002-05-31 |
| EP0643068A4 (en) | 1995-08-02 |
| KR950701640A (ko) | 1995-04-28 |
| YU36693A (sh) | 1996-07-24 |
| CA2117883A1 (en) | 1993-12-09 |
| CA2117883C (en) | 2003-10-21 |
| YU48771B (sh) | 1999-12-27 |
| IL105810A0 (en) | 1993-09-22 |
| DE69320476T2 (de) | 1999-03-25 |
| US5658888A (en) | 1997-08-19 |
| CN1081184A (zh) | 1994-01-26 |
| TW240230B (ko) | 1995-02-11 |
| KR100226311B1 (ko) | 1999-10-15 |
| SG52785A1 (en) | 1998-09-28 |
| EP0643068A1 (en) | 1995-03-15 |
| CN1036199C (zh) | 1997-10-22 |
| WO1993024509A1 (en) | 1993-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69320476D1 (en) | Erythromycinderivate | |
| CA2311742A1 (en) | 6-amino-9-benzyl-8-hydroxypurine derivatives | |
| DE69127457D1 (en) | 6-0-methylerythromycin a-derivat | |
| KR100202474B1 (en) | Novel tetrapeptide derivative | |
| DK0528678T3 (da) | Pyrrolidylthiocarbapenemderivat med antibakteriel aktivitet | |
| EP0324387A3 (en) | Composition for treatment of ischemic disorder in organs | |
| YU54189A (en) | Process for obtaining cephem derivatives and midproducts for the same | |
| IL91047A (en) | Zinc complexes for the treatment of free radical- induced diseases | |
| EP0522173A4 (en) | 4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof | |
| NO941451L (ko) | ||
| EP0696585A4 (ko) | ||
| ES8503354A1 (es) | Un procedimiento de preparacion de nuevos derivados de carbapenem. | |
| ATE90685T1 (de) | Disaccharidderivate. | |
| DK540589A (da) | Pyrrolidinderivater | |
| EP0229313A3 (en) | Compound related to antibiotic tan-749 and their production | |
| MY106269A (en) | Novel antimicrobial quinolonyl lactam esters. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
| B1PR | Patent granted | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20090518 Year of fee payment: 17 |
|
| PBON | Lapse due to non-payment of renewal fee |
Effective date: 20100525 |